All In Biotech

Drug Trial Radar · NCT00631371

Study Comparing Bevacizumab + Temsirolimus vs. Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects

Phase 3b, Randomized, Open-Label Study Of Bevacizumab + Temsirolimus Vs. Bevacizumab + Interferon-Alfa As First-Line Treatment In Subjects With Advanced Renal Cell Carcinoma

Last checked: Nov 20, 2026Latest source record: Apr 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 791 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

791

Actual

Start

Apr 2008

Primary completion

Apr 2012

Study completion Apr 2015

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Mar 7, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary objective: Comparison of independently assessed progression free survival (PFS) in subjects administered Bevacizumab + Temsirolimus vs. those administered Bevacizumab + Interferon-Alfa. Secondary objectives: safety, Investigator assessed PFS, objective response rate (independently assessed), and overall survival.

Conditions

  • Renal Cell Carcinoma

Interventions

  • BevacizumabDrug

    Bevacizumab 10 mg/kg intravenous (IV) q8wks

  • TemsirolimusDrug

    Temsirolimus 25 mg IV weekly

  • BevacizumabDrug

    Bevacizumab 10 mg/kg intravenous (IV) q8wks

  • Interferon-Alfa 9MUDrug

    Interferon-Alfa 9MU SC TIW

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-Free Survival (PFS): Independent-AssessmentTime frame: Baseline until disease progression, initiation of new anticancer treatment, or death, assessed every 8 weeks (up to cut-off date: 19 April 2012)

Locations

172 sites in 30 countries. Site status is shown where the registry gives one.

  • Hematology Oncology Services of Arkansas

    Little Rock, Arkansas

  • South County Hematology/Oncology

    Chula Vista, California

  • Cancer Center Oncology Medical Group

    La Mesa, California

  • UCLA Medical Center

    Los Angeles, California

  • UCLA

    Los Angeles, California

  • UCLA

    Los Angeles, California

  • North County Oncology Medical Clinic

    Oceanside, California

  • Medical Oncology Associates - SD

    San Diego, California

  • Sharp Memorial Hospital Investigational Pharmacy

    San Diego, California

  • Sharp Rees-Stealy

    San Diego, California

  • California Pacific Medical Center

    San Francisco, California

  • Pacific Hematology/Oncology Associates

    San Francisco, California

  • San Francisco Oncology Associates

    San Francisco, California

  • Cohen & Hufford MD's INC

    San Francisco, California

  • The Jones Clinic, PC

    New Albany, Mississippi

  • The Cleveland Clinic

    Cleveland, Ohio

  • Edmond Oncology Center

    Edmond, Oklahoma

  • OU Medical Center

    Oklahoma City, Oklahoma

  • OU Physician's Building

    Oklahoma City, Oklahoma

  • University of Oklahoma

    Oklahoma City, Oklahoma

  • The Jones Clinic, PC

    Germantown, Tennessee

  • The Vanderbilt Clinic

    Nashville, Tennessee

  • University of Washington Medical Center

    Seattle, Washington

  • Virginia Mason Medical Center

    Seattle, Washington

  • Seattle Cancer Care Alliance

    Seattle, Washington

  • Centro Oncológico Rosario

    Rosario, Santa Fe Province, Argentina

  • ISIS Clinica Especializado

    Santa Fe, Santa Fe Province, Argentina

  • Centro Medico San Roque

    San Miguel de Tucumán, Tucumán Province, Argentina

  • Cancer Care SA

    Kurralta Park, Australia

  • Mater Private Hospital

    South Brisbane, Australia

  • Mater Adult Hospital

    South Brisbane, Queensland, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Ashford Cancer Center Research

    Kurralta Park, South Australia, Australia

  • ZNA Middelheim

    Antwerp, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • Jessa Ziekenhuis - campus Virga Jessa

    Hasselt, Belgium

  • Cliniques Universitaires de Mont-Godinne UCL

    Mont-Godinne, Belgium

  • Irmandade da Santa Casa de Misericordia de Porto Alegre

    Porto Alegre, Brazil

  • Centro Goiano de Oncologia

    Goiânia, Goiás, Brazil

  • Centro Goiano de Oncologia - CGO

    Goiânia, Goiás, Brazil

Showing 40 of 172 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.